AZE Share Price Performance
€0
-11.99 (-100.00%)
Price €0
Fair Value€13.73
Share Pricen/a
Narrative Update • Sep 03
Azelis Group NV Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
AZE Community Narratives
AN
Fair Value
·Fair Value €13.73 12.6% undervalued intrinsic discount
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
Fair Value
·Fair Value €16 25.0% undervalued intrinsic discount
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value €10.45 14.9% overvalued intrinsic discount
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Azelis Group
12.6% undervalued intrinsic discount
Recovery Will Likely Emerge After Industry Pressures Ease In 2026
View narrativeAN
Updated 3 Sep
Azelis Group
14.9% overvalued intrinsic discount
Specialty Chemicals Will Endure Market Headwinds With Gradual Relief
View narrativeAN
Updated 14 Aug
Azelis Group
25.0% undervalued intrinsic discount
Rising Demand For Specialty Chemicals Will Fuel Market Expansion
View narrativeAN
Updated 15 Jun
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
AZE: Repriced Risk Outlook Will Be Supported By Margin Recovery
Fair Value: €13.73 12.6% undervalued intrinsic discount
9 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AZE: Elevated Expectations Will Test Execution Risk At Current Levels
Fair Value: €10.45 14.9% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AZE: Dividend Policy And Buybacks Will Support A More Constructive Outlook
Fair Value: €16 25.0% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Azelis Group NV Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 22, 2026
- 0.46
- 23.21%
- 2.74%
- 58.7%
About AZE
- Founded
- 1996
- Employees
- 4000
- CEO
- WebsiteView website
Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.
Recent AZE News & Updates
Narrative Update • Aug 14
AZE: Elevated Expectations Will Test Execution Risk At Current Levels
Analysts have lifted their fair value estimate for Azelis Group to €10.45 from €10.00, citing higher published price targets such as the move to €14.70 and €10.50, along with a view that key risks are now better reflected in the stock. Analyst Commentary Recent price target changes on Azelis Group point to a more balanced view, with some analysts seeing upside potential while others stress that risks around execution and growth remain important for investors to watch.Narrative Update • Jul 30
